Catalyst Pharmaceuticals Inc (CPRX)
21.74
-0.14
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
21.74
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Total Liabilities (Quarterly): 97.70M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 97.70M |
| March 31, 2024 | 85.26M |
| December 31, 2023 | 82.23M |
| September 30, 2023 | 64.66M |
| June 30, 2023 | 68.60M |
| March 31, 2023 | 73.57M |
| December 31, 2022 | 75.21M |
| September 30, 2022 | 63.07M |
| June 30, 2022 | 26.22M |
| March 31, 2022 | 26.75M |
| December 31, 2021 | 30.96M |
| September 30, 2021 | 24.59M |
| June 30, 2021 | 20.19M |
| March 31, 2021 | 18.56M |
| December 31, 2020 | 22.76M |
| September 30, 2020 | 18.23M |
| June 30, 2020 | 20.21M |
| March 31, 2020 | 18.20M |
| December 31, 2019 | 24.75M |
| September 30, 2019 | 18.71M |
| June 30, 2019 | 14.95M |
| March 31, 2019 | 9.901M |
| December 31, 2018 | 9.666M |
| September 30, 2018 | 3.633M |
| June 30, 2018 | 3.225M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.882M |
| December 31, 2017 | 4.424M |
| September 30, 2017 | 2.902M |
| June 30, 2017 | 2.011M |
| March 31, 2017 | 2.601M |
| December 31, 2016 | 2.398M |
| September 30, 2016 | 2.410M |
| June 30, 2016 | 2.616M |
| March 31, 2016 | 3.129M |
| December 31, 2015 | 4.625M |
| September 30, 2015 | 3.913M |
| June 30, 2015 | 5.545M |
| March 31, 2015 | 9.428M |
| December 31, 2014 | 8.666M |
| September 30, 2014 | 9.222M |
| June 30, 2014 | 4.741M |
| March 31, 2014 | 4.591M |
| December 31, 2013 | 3.978M |
| September 30, 2013 | 6.576M |
| June 30, 2013 | 2.701M |
| March 31, 2013 | 1.548M |
| December 31, 2012 | 2.167M |
| September 30, 2012 | 2.710M |
| June 30, 2012 | 1.293M |
| March 31, 2012 | 2.272M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.20M
Minimum
Mar 2020
97.70M
Maximum
Jun 2024
45.35M
Average
26.75M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 2.347B |
| Vertex Pharmaceuticals Inc | 5.357B |
| Regenxbio Inc | 221.11M |
| Edgewise Therapeutics Inc | 21.17M |
| Entrada Therapeutics Inc | 152.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 706.36M |
| Shareholders Equity (Quarterly) | 608.66M |
| Current Ratio | 5.139 |